CD38 expression enhances sensitivity of lymphoma T and B cell lines to biochemical and receptor-mediated apoptosis

Cell Biology International

Volumn 30, Issue 9, 2006, Pages 727-732

  Gregorini, Armando ^a   Tomasetti, Marco ^b   Cinti, Cristina ^b   Colomba, Daniela ^c   Colomba, Stella ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Apoptosis; CD38; Lymphoma B cells; Lymphoma T cells; Myeloid leukemia cells

Indexed keywords

ANNEXIN; ANTISENSE OLIGONUCLEOTIDE; CD38 ANTIGEN; COMPLEMENTARY DNA; FLUORESCEIN ISOTHIOCYANATE; HYDROGEN PEROXIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL SELECTION; CELL SUBPOPULATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL LINE; LYMPHOMA; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; RAJI CELL; RECEPTOR BINDING; T CELL LYMPHOMA; ULTRAVIOLET B RADIATION;

ANNEXIN A5; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CELL LINE, TUMOR; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; HYDROGEN PEROXIDE; JURKAT CELLS; K562 CELLS; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; OLIGONUCLEOTIDES, ANTISENSE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TOCOPHEROLS; ULTRAVIOLET RAYS; VITAMIN E;

TOSCANA VIRUS;

EID: 33748325899     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2006.05.004     Document Type: Article

References (20)

1. +-converting ectoenzymes. Curr Trends Immunol 2 (1999) 19-36
2. Deaglio S., Mehta K., and Malavasi F. Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk Res 25 (2001) 1-12
3. Deaglio S., Zubiaur M., Gregorini A., Bottarel F., Ausiello C.M., Dianzani U., et al. Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood 99 (2002) 2490-2498
4. Deaglio S., Vaisitti T., Bergui L., Bonello L., Horenstein A.L., Tamagnone L., et al. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood 105 8 (2005) 3042-3050
5. De Flora A., Franco L., Guida L., Bruzzone S., and Zocchi E. Ectocellular CD38-catalyzed synthesis and intracellular Ca(2+)-mobilizing activity of cyclic ADP-ribose. Cell Byochem Biophys 28 (1998) 45-62
6. +-converting enzymes. J Immunol 159 (1997) 3858-3865
7. Green D.R. Apoptotic pathways: paper wraps stone blunts scissors. Cell 102 (2000) 1-4
8. Gregorini A., Cinti C., Pigliapoco F., Deaglio S., Ferrero E., Papa S., et al. Rapid and sensitive detection of recombinant soluble proteins in the supernatant of transfected mammalian cells. J Biol Regul Homeost Agents 16 (2002) 93-97
9. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
10. Howard M., Grimaldi J.C., Bazan J.F., Lund F.E., Santos-Argumedo L., Parkhouse R.M., et al. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 262 (1993) 1056-1059
11. Ibrahim S., Keating M., Do K.A., O'Brien S., Huh Y.O., Jilani I., et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukaemia. Blood 98 1 (2001) 181-186
12. Keyhani A., Huh Y.O., Jendiroba D., Pagliaro L., Cortez J., Pierce S., et al. Increased CD38 expression is associated with favorable prognosis in adult acute leukemia. Leuk Res 24 2 (2000) 153-159
13. Malavasi F., Funaro A., Alessio M., DeMonte L.B., Ausiello C.M., Dianzani U., et al. CD38: a multi-lineage cell activation molecule with a split personality. Int J Clin Lab Res 22 2 (1992) 73-80
14. Martin S.J., Reutelingsperger C.P.M., and Green D.R. Annexin V: a specific probe for apoptotic cells. In: Cotter T.G., and Martin S.J. (Eds). Techniques in apoptosis: a user's guide (1996), Portland Press, London 107-119
15. Matrai Z. CD38 as a prognostic marker in CLL. Hematology 10 1 (2005) 39-46
16. Mehta K., Shahid U., and Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J 10 (1996) 1408-1417
17. Morabito F., Mangiola M., Stelitano C., Deaglio S., Callea V., and Malavasi F. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. Haematologica 87 (2002) 217-218
18. Shubinsky G., and Schlesinger M. The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer. Immunity 7 (1997) 315-324
19. Tenca C., Merlo A., Zarcone D., Saverino D., Bruno S., De Santanna A., et al. Death of T cell precursors in the human thymus: a role for CD38. Int Immunol 15 (2003) 1105-1116
20. Zupo S., Isnardi L., Megna M., Massara R., Malavasi F., Dono M., et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 88 4 (1996) 1365-1374